Transaction in Own Shares

PureTech Health PLC
02 February 2024
 

2 February 2024

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:             

1 February 2024



Number of ordinary shares purchased:

87,581



Highest price paid per share:

198.00p



Lowest price paid per share:

194.40p



Volume weighted average price paid per share:

197.26p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 19,288,866 ordinary shares in treasury and has 270,179,293 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 270,179,293 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

01/02/2024

12:49:28

238

197.2

AQXE

00388179512TRLO0.1.1

01/02/2024

12:49:28

492

197.2

BATE

00388179513TRLO0.1.1

01/02/2024

12:49:28

122

197.2

CHIX

00388179514TRLO0.1.1

01/02/2024

12:49:28

34

197.2

CHIX

00388179515TRLO0.1.1

01/02/2024

12:49:28

336

197.2

CHIX

00388179516TRLO0.1.1

01/02/2024

12:49:28

17

197

XLON

00388179517TRLO0.1.1

01/02/2024

12:49:28

482

197

XLON

00388179518TRLO0.1.1

01/02/2024

12:49:28

977

197

XLON

00388179519TRLO0.1.1

01/02/2024

12:49:28

956

197

XLON

00388179520TRLO0.1.1

01/02/2024

12:49:28

12

197.2

CHIX

00388179521TRLO0.1.1

01/02/2024

12:49:28

264

197.2

CHIX

00388179522TRLO0.1.1

01/02/2024

12:56:46

14948

198

XLON

00388180931TRLO0.1.1

01/02/2024

12:56:46

1014

198

XLON

00388180932TRLO0.1.1

01/02/2024

12:56:46

3057

198

XLON

00388180933TRLO0.1.1

01/02/2024

12:56:46

413

198

XLON

00388180935TRLO0.1.1

01/02/2024

12:56:46

427

198

XLON

00388180934TRLO0.1.1

01/02/2024

12:56:46

238

198

XLON

00388180936TRLO0.1.1

01/02/2024

12:56:46

6991

198

XLON

00388180937TRLO0.1.1

01/02/2024

12:56:49

395

198

CHIX

00388180967TRLO0.1.1

01/02/2024

12:57:39

492

197.8

XLON

00388181171TRLO0.1.1

01/02/2024

12:57:44

433

197.8

CHIX

00388181223TRLO0.1.1

01/02/2024

13:01:14

390

197.8

XLON

00388181854TRLO0.1.1

01/02/2024

13:04:17

200

197.8

XLON

00388182273TRLO0.1.1

01/02/2024

13:10:22

141

197.8

XLON

00388183333TRLO0.1.1

01/02/2024

13:12:21

32

197.8

CHIX

00388183524TRLO0.1.1

01/02/2024

13:18:25

12

197.8

CHIX

00388184519TRLO0.1.1

01/02/2024

13:20:01

82

197.2

AQXE

00388184801TRLO0.1.1

01/02/2024

13:20:01

974

197.8

XLON

00388184802TRLO0.1.1

01/02/2024

13:20:40

116

197.8

CHIX

00388184908TRLO0.1.1

01/02/2024

13:28:08

530

197.8

XLON

00388186264TRLO0.1.1

01/02/2024

13:28:22

145

197.8

CHIX

00388186274TRLO0.1.1

01/02/2024

14:21:14

316

198

AQXE

00388196735TRLO0.1.1

01/02/2024

14:21:16

275

198

BATE

00388196750TRLO0.1.1

01/02/2024

14:27:58

15

198

XLON

00388198391TRLO0.1.1

01/02/2024

14:27:58

3218

198

XLON

00388198392TRLO0.1.1

01/02/2024

14:27:58

829

198

XLON

00388198393TRLO0.1.1

01/02/2024

14:27:58

3709

198

XLON

00388198394TRLO0.1.1

01/02/2024

14:27:58

326

198

XLON

00388198395TRLO0.1.1

01/02/2024

14:29:39

492

198

XLON

00388198824TRLO0.1.1

01/02/2024

14:30:10

204

198

CHIX

00388199838TRLO0.1.1

01/02/2024

14:31:38

492

198

XLON

00388200849TRLO0.1.1

01/02/2024

14:33:04

196

198

CHIX

00388201543TRLO0.1.1

01/02/2024

14:33:25

492

198

XLON

00388201837TRLO0.1.1

01/02/2024

14:35:10

492

198

XLON

00388202509TRLO0.1.1

01/02/2024

14:36:57

492

198

XLON

00388203280TRLO0.1.1

01/02/2024

14:38:39

492

198

XLON

00388204143TRLO0.1.1

01/02/2024

14:40:25

58

198

XLON

00388204676TRLO0.1.1

01/02/2024

14:40:25

434

198

XLON

00388204677TRLO0.1.1

01/02/2024

14:42:11

492

198

XLON

00388205483TRLO0.1.1

01/02/2024

14:43:54

492

198

XLON

00388206212TRLO0.1.1

01/02/2024

14:45:39

492

198

XLON

00388207628TRLO0.1.1

01/02/2024

14:46:24

172

198

CHIX

00388208954TRLO0.1.1

01/02/2024

14:47:26

492

198

XLON

00388210812TRLO0.1.1

01/02/2024

14:49:09

492

198

XLON

00388212446TRLO0.1.1

01/02/2024

14:50:53

271

198

XLON

00388213609TRLO0.1.1

01/02/2024

14:50:53

221

198

XLON

00388213610TRLO0.1.1

01/02/2024

14:52:17

33

198

CHIX

00388214402TRLO0.1.1

01/02/2024

14:52:42

492

198

XLON

00388214639TRLO0.1.1

01/02/2024

14:54:26

492

198

XLON

00388215504TRLO0.1.1

01/02/2024

14:56:17

492

198

XLON

00388216433TRLO0.1.1

01/02/2024

14:57:52

492

198

XLON

00388217391TRLO0.1.1

01/02/2024

14:59:36

492

198

XLON

00388218269TRLO0.1.1

01/02/2024

15:00:47

492

197.4

CHIX

00388219360TRLO0.1.1

01/02/2024

15:00:47

492

197.4

BATE

00388219361TRLO0.1.1

01/02/2024

15:00:47

128

197.4

TRQX

00388219363TRLO0.1.1

01/02/2024

15:00:47

492

197.4

BATE

00388219362TRLO0.1.1

01/02/2024

15:00:47

238

197.4

AQXE

00388219364TRLO0.1.1

01/02/2024

15:00:47

128

197.4

TRQX

00388219365TRLO0.1.1

01/02/2024

15:00:47

2460

197.4

XLON

00388219367TRLO0.1.1

01/02/2024

15:00:47

238

197.4

AQXE

00388219366TRLO0.1.1

01/02/2024

15:04:02

204

197.2

AQXE

00388221481TRLO0.1.1

01/02/2024

15:04:02

492

197

CHIX

00388221482TRLO0.1.1

01/02/2024

15:04:04

492

197

XLON

00388221486TRLO0.1.1

01/02/2024

15:04:11

837

197.4

BATE

00388221610TRLO0.1.1

01/02/2024

15:16:45

204

196.8

AQXE

00388227468TRLO0.1.1

01/02/2024

15:28:03

238

196.8

AQXE

00388231685TRLO0.1.1

01/02/2024

15:28:03

492

196.8

BATE

00388231686TRLO0.1.1

01/02/2024

15:28:03

492

196.8

BATE

00388231687TRLO0.1.1

01/02/2024

15:28:03

492

196.8

XLON

00388231688TRLO0.1.1

01/02/2024

15:28:03

492

196.8

XLON

00388231689TRLO0.1.1

01/02/2024

15:28:03

492

196.8

XLON

00388231690TRLO0.1.1

01/02/2024

15:28:03

492

196.8

XLON

00388231691TRLO0.1.1

01/02/2024

15:28:03

128

196.6

TRQX

00388231692TRLO0.1.1

01/02/2024

15:33:30

2

197.2

XLON

00388233796TRLO0.1.1

01/02/2024

15:33:30

244

196.6

AQXE

00388233797TRLO0.1.1

01/02/2024

15:48:37

492

196.6

BATE

00388239073TRLO0.1.1

01/02/2024

15:48:37

492

196.6

CHIX

00388239074TRLO0.1.1

01/02/2024

15:48:37

128

196.6

TRQX

00388239076TRLO0.1.1

01/02/2024

15:48:37

492

196.6

CHIX

00388239075TRLO0.1.1

01/02/2024

15:48:37

646

196.6

XLON

00388239077TRLO0.1.1

01/02/2024

15:48:37

1322

196.6

XLON

00388239078TRLO0.1.1

01/02/2024

15:48:37

982

196.6

XLON

00388239079TRLO0.1.1

01/02/2024

15:48:43

297

196.4

XLON

00388239242TRLO0.1.1

01/02/2024

15:48:43

80

196.4

XLON

00388239243TRLO0.1.1

01/02/2024

15:48:45

841

196.6

BATE

00388239286TRLO0.1.1

01/02/2024

15:54:22

36

195.8

CHIX

00388241733TRLO0.1.1

01/02/2024

15:54:22

70

195.8

BATE

00388241734TRLO0.1.1

01/02/2024

15:54:22

422

195.8

BATE

00388241735TRLO0.1.1

01/02/2024

15:54:22

456

195.8

CHIX

00388241736TRLO0.1.1

01/02/2024

15:54:22

492

195.8

CHIX

00388241737TRLO0.1.1

01/02/2024

15:54:22

129

195.8

XLON

00388241738TRLO0.1.1

01/02/2024

15:54:22

600

195.8

XLON

00388241739TRLO0.1.1

01/02/2024

15:54:22

142

195.8

XLON

00388241740TRLO0.1.1

01/02/2024

15:54:22

2081

195.8

XLON

00388241741TRLO0.1.1

01/02/2024

15:54:23

446

195.8

CHIX

00388241746TRLO0.1.1

01/02/2024

15:54:25

512

196.4

TRQX

00388241769TRLO0.1.1

01/02/2024

15:57:44

607

196.4

XLON

00388243873TRLO0.1.1

01/02/2024

15:58:41

325

196.4

XLON

00388244587TRLO0.1.1

01/02/2024

15:59:54

121

196.4

XLON

00388245243TRLO0.1.1

01/02/2024

16:00:35

19

196

CHIX

00388245587TRLO0.1.1

01/02/2024

16:00:35

34

196

CHIX

00388245588TRLO0.1.1

01/02/2024

16:00:35

439

196

CHIX

00388245589TRLO0.1.1

01/02/2024

16:00:35

2460

196

XLON

00388245590TRLO0.1.1

01/02/2024

16:00:39

266

195.6

AQXE

00388245621TRLO0.1.1

01/02/2024

16:00:39

93

195.6

AQXE

00388245622TRLO0.1.1

01/02/2024

16:00:39

19

195.6

AQXE

00388245623TRLO0.1.1

01/02/2024

16:08:32

370

196

XLON

00388249147TRLO0.1.1

01/02/2024

16:13:05

7

195.4

AQXE

00388251343TRLO0.1.1

01/02/2024

16:13:05

58

195.4

CHIX

00388251344TRLO0.1.1

01/02/2024

16:13:05

301

195.4

XLON

00388251345TRLO0.1.1

01/02/2024

16:18:44

348

195.4

CHIX

00388254913TRLO0.1.1

01/02/2024

16:18:44

86

195.4

CHIX

00388254914TRLO0.1.1

01/02/2024

16:18:44

65

195.4

TRQX

00388254916TRLO0.1.1

01/02/2024

16:18:44

63

195.4

TRQX

00388254915TRLO0.1.1

01/02/2024

16:18:44

499

195.4

XLON

00388254917TRLO0.1.1

01/02/2024

16:18:44

94

195

BATE

00388254919TRLO0.1.1

01/02/2024

16:18:44

230

195.4

XLON

00388254918TRLO0.1.1

01/02/2024

16:18:44

370

195.4

XLON

00388254920TRLO0.1.1

01/02/2024

16:18:44

122

195.4

XLON

00388254921TRLO0.1.1

01/02/2024

16:18:44

160

195

BATE

00388254922TRLO0.1.1

01/02/2024

16:18:44

478

195.4

XLON

00388254923TRLO0.1.1

01/02/2024

16:18:44

14

195.4

XLON

00388254924TRLO0.1.1

01/02/2024

16:18:44

586

195.4

XLON

00388254925TRLO0.1.1

01/02/2024

16:18:44

55

195.4

XLON

00388254926TRLO0.1.1

01/02/2024

16:18:44

106

195.4

XLON

00388254927TRLO0.1.1

01/02/2024

16:18:44

288

195.2

XLON

00388254928TRLO0.1.1

01/02/2024

16:18:48

17

195

BATE

00388254967TRLO0.1.1

01/02/2024

16:18:48

20

195

BATE

00388254968TRLO0.1.1

01/02/2024

16:18:48

10

195

BATE

00388254969TRLO0.1.1

01/02/2024

16:18:50

25

195

BATE

00388254995TRLO0.1.1

01/02/2024

16:18:51

73

195

BATE

00388255004TRLO0.1.1

01/02/2024

16:19:00

76

195

BATE

00388255081TRLO0.1.1

01/02/2024

16:19:38

13

195

XLON

00388255413TRLO0.1.1

01/02/2024

16:19:38

213

195

XLON

00388255414TRLO0.1.1

01/02/2024

16:21:37

419

195

CHIX

00388256485TRLO0.1.1

01/02/2024

16:21:39

1300

194.8

XLON

00388256519TRLO0.1.1

01/02/2024

16:21:39

55

194.8

XLON

00388256520TRLO0.1.1

01/02/2024

16:21:39

442

194.8

XLON

00388256521TRLO0.1.1

01/02/2024

16:22:18

15

194.4

TRQX

00388256852TRLO0.1.1

01/02/2024

16:28:04

508

195.4

XLON

00388259835TRLO0.1.1

01/02/2024

16:29:17

984

195.4

XLON

00388260529TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100